Glenmark Pharma gets USFDA nod for Chlorzoxazone Tablets ruchika27 May 2020 9:26 AM GMTThis marks Glenmark’s first ANDA approval out of their new North American manufacturing facility based in Monroe, North Carolina
Sanofi plans to sell its equity investment in Regeneron; confirms no change to ongoing collaboration Hina Zahid27 May 2020 8:47 AM GMTParis: Sanofi has announced its intent to sell its equity investment in Regeneron through a registered public offering and related share repurchase by ...
UK confirms launch of new trial for Remdesivir in coronavirus ruchika27 May 2020 7:47 AM GMTLondon: The UK government on Tuesday confirmed the launch of a new trial for selected coronavirus patients of remdesivir, a drug which is believed to s...
Indoco Remedies gets USFDA nod for Succinylcholine Chloride Injection ruchika27 May 2020 6:17 AM GMTThe product is being used for some patients infected with Coronavirus (COVID-19)
Deepak Fertilisers forays into alcohol-based hand sanitiser space ruchika26 May 2020 1:54 PM GMTDeepak Fertilisers launches Alcohol-based hand-sanitiser
Glenmark to Commence Another New Phase 3 Clinical Trial India testing on Combination of Favipiravir, Umifenovir Moderate COVID-19 hospitalised patients ruchika26 May 2020 8:18 AM GMTThe new combination clinical trial will be called FAITH - (Favipiravir plus Umifenovir (efficacy & safety) Trial in an Indian Hospital setting)
Daiichi Sankyo Launches ENHERTU in Japan for Patients with HER2 Positive Unresectable or Metastatic Breast Cancer ruchika26 May 2020 7:23 AM GMTTokyo, Munich: Daiichi Sankyo Company, Limited has announced the launch of ENHERTU® (trastuzumab deruxtecan), a HER2 directed antibody drug conjugate (...
West Pharmaceutical Services, Inc. to Join S&P 500 Index ruchika26 May 2020 4:45 AM GMTThe S&P 500® is a widely regarded index of large-cap U.S. equities
Dupixent met co-primary endpoints in Part A of Phase 3 trial: Regeneron, Sanofi ruchika25 May 2020 11:55 AM GMTDupixent is a fully-human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) proteins.
Cipla, Hetero approach DCGI seeking waiver of Clinical Trial of Remdesivir in India: Report MD Bureau25 May 2020 11:29 AM GMTNew Delhi: With pharma companies across the country making efforts to get the first-mover advantage in bringing potential coronavirus treatments, two...
Bristol Myers Squibb gets EMA validation for Idecabtagene Vicleucel, CC-486 ruchika25 May 2020 10:23 AM GMTPrinceton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Applications (MAA) for...
COVID 19: Natco Pharma supports Columbia University trials for CQ tablets to prevent infections ruchika25 May 2020 8:00 AM GMTThe company said researchers at Columbia University are conducting this critical study to assess CQ as prophylaxis against COVID-19 in healthcare...
